CervoMed Inc expected to post a loss of 87 cents a share - Earnings Preview
CervoMed Inc <CRVO.OQ> expected to post a loss of 87 cents a share - Earnings Preview
CervoMed Inc CRVO.OQ CRVO.O is expected to show a fall in quarterly revenue when it reports results on August 6 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for CervoMed Inc is for a loss of 87 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for CervoMed Inc is $20.00, about 669.2% above its last closing price of $2.60
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | -0.85 | -0.78 | -0.86 | Missed | -10.3 |
Dec. 31 2026 | -0.74 | -0.72 | -0.88 | Missed | -22.7 |
Sep. 30 2025 | -0.76 | -0.77 | -0.84 | Missed | -8.8 |
Jun. 30 2025 | -0.59 | -0.63 | -0.70 | Missed | -11.1 |
Mar. 31 2025 | -0.67 | -0.66 | -0.56 | Beat | 15 |
Dec. 31 2024 | -0.68 | -0.63 | -0.80 | Missed | -27 |
Sep. 30 2024 | -0.40 | -0.41 | -0.55 | Missed | -33.3 |
Jun. 30 2024 | -0.26 | -0.31 | -0.27 | Beat | 11.8 |
This summary was machine generated August 4 at 13:23 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)